Found: 16
Select item for more details and to access through your institution.
PCI29732, a Bruton's Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 48, n. 6, p. 2302, doi. 10.1159/000492647
- By:
- Publication type:
- Article
Reversal of ABCB1-related multidrug resistance by ERK5-IN-1.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-1537-9
- By:
- Publication type:
- Article
Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1117096
- By:
- Publication type:
- Article
Disease Status–Dependent Drug–Herb Interactions: NASH Lowered the Risk of Hepatotoxicity in Rats Coadministered With Simvastatin and Gardenia jasminoides J. Ellis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.622040
- By:
- Publication type:
- Article
Vandetanib (Zactima, ZD6474) Antagonizes ABCC1- and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function.
- Published in:
- PLoS ONE, 2009, v. 4, n. 4, p. 1, doi. 10.1371/journal.pone.0005172
- By:
- Publication type:
- Article
MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing.
- Published in:
- Drugs & Drug Candidates, 2023, v. 2, n. 3, p. 591, doi. 10.3390/ddc2030031
- By:
- Publication type:
- Article
Anthracenedione Derivatives as Anticancer Agents Isolated from Secondary Metabolites of the Mangrove Endophytic Fungi.
- Published in:
- Marine Drugs, 2010, v. 8, n. 4, p. 1469, doi. 10.3390/md8041469
- By:
- Publication type:
- Article
Anticancer Effect and Structure-Activity Analysis of Marine Products Isolated from Metabolites of Mangrove Fungi in the South China Sea.
- Published in:
- Marine Drugs, 2010, v. 8, n. 4, p. 1094, doi. 10.3390/md8041094
- By:
- Publication type:
- Article
BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01698-4
- By:
- Publication type:
- Article
Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00288
- By:
- Publication type:
- Article
Intestinal absorption and hepatic elimination of drugs in high‐fat high‐cholesterol diet‐induced non‐alcoholic steatohepatitis rats: exemplified by simvastatin.
- Published in:
- British Journal of Pharmacology, 2021, v. 178, n. 3, p. 582, doi. 10.1111/bph.15298
- By:
- Publication type:
- Article
Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G<sub>0</sub>/G<sub>1</sub> cell cycle arrest and apoptosis.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 3, p. 707, doi. 10.1002/ijc.27694
- By:
- Publication type:
- Article
Axitinib Targeted Cancer Stemlike Cells to Enhance Efficacy of Chemotherapeutic Drugs via Inhibiting the Drug Transport Function of ABCG2.
- Published in:
- Molecular Medicine, 2012, v. 18, n. 5, p. 887, doi. 10.2119/molmed.2011.00444
- By:
- Publication type:
- Article
Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.
- Published in:
- British Journal of Pharmacology, 2012, v. 166, n. 5, p. 1669, doi. 10.1111/j.1476-5381.2012.01849.x
- By:
- Publication type:
- Article
Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block "eat-me" signal.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01545-x
- By:
- Publication type:
- Article